Stock Spotlight Archives - Page 76 of 383

FridayJan 13, 2023 12:46 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Opportunity Following Recent Exploratory Work at Its Iska Iska Project

Eloro Resources’ (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) EVP of Exploration Bill Pearson was recently part of an interview on Business TV (“BTV”) where he expressed his optimism on the company’s prospects following its recent exploratory work at its Iska Iska project located in southern Bolivia. “[Pearson also simultaneously suggested] that the possibility that Eloro could potentially uncover a world-class, multimillion-ounce deposit of silver and tin within the Iska Iska project may not be far off from the realm of possibility. Over the past two years, Eloro Resources has drilled upwards of 102 holes and over 70,000 cumulative meters across…

FridayJan 13, 2023 12:36 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc. Reinventing Home Energy Market

GeoSolar Technologies (“GST”) offers its SmartGreen(TM) solution, which can be retrofitted to existing homes or built into new developments in any climate with an installation process that takes just a few weeks. “The comprehensive program includes sealing and insulating the ‘shell’ or ‘envelope’ of the house (exterior walls, attic, etc.), eliminating any usage of fossil fuels (natural gas, heating oil, propane) in favor of high-efficiency electric appliances and mechanicals, and installation of rooftop solar panels as the new energy source, geothermal ground loops used in heating and cooling, electric heat pump and water heater, floor loops, LED lighting, air purification…

ThursdayJan 12, 2023 2:28 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Closer Toward Broad Applications of Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX) in 2022 achieved crucial milestones centered around its patented DehydraTECH(TM) drug delivery technology. “For Lexaria, the end goal does not only lie in uncovering DehydraTECH’s ability to improve the bioavailability of various APIs. Instead, the company is keen on establishing whether DehydraTECH can be applied broadly within the pharmaceutical industry. And calendar 2022 has brought Lexaria closer to realizing this goal, with the company initiating a slew of research programs, many of which it has already completed. Moreover, its intellectual property (‘IP’) portfolio received additional patent protection in different jurisdictions around the world. Lexaria also…

ThursdayJan 12, 2023 2:18 pm

QualityStocksNewsBreaks – Coyuchi Inc. Positioned to Propel Its New Growth Phase

Coyuchi is setting the gold standard in sustainable luxury home goods, offering organic bedding, sheets, towels, apparel, and more for the environmentally conscious home. “For 30 years, Coyuchi has explored organic farming and sustainable textiles, and guarantees the highest environmental and ethical standards through its acquisition of certifications, including the Global Organic Textile Standard (‘GOTS’), Fair Trade Certified, and MADE SAFE(R). Backed by a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base driving the fast-growing organic luxury market, Coyuchi is positioned to propel its new growth phase as the world awakens to sustainability at scale,”…

WednesdayJan 11, 2023 12:03 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine

Aditxt (NASDAQ: ADTX), a biotech innovation company, is developing and commercializing technologies with a focus on monitoring and modulating, mapping and reprogramming the immune system, designing technologies to provide a personalized immune profile. “In late October 2022, Aditxt announced the creation of its Adimune(TM) program. At the same time, Aditxt announced that Adimune initiated the GMP manufacturing of drug candidate ADI(TM)-100 for purposes of initiating human trials. The trial will be performed in autoimmune diseases, with psoriasis as the first indication to be studied. Adimune’s nucleic acid-based technology, ADI(TM), has shown in preclinical studies the ability to restore/induce immune tolerance…

WednesdayJan 11, 2023 11:41 am

QualityStocksNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Stands Distinct in Mineral Exploration Space with Kay Mine Project

Arizona Metals (TSX: AMC) (OTCQX: AZMCF), a mineral exploration company focused on advancing precious and base metal deposits, has commenced its phase 3 expansion drill program in the flagship Kay Mine Project. The copper-gold-zinc-silver asset is located in Yavapai County on a combination of private land and BLM claims. “Arizona Metals prides itself on having unique features that distinguish the company in the market. The first quality is the Kay Mine Project’s grade and width. Next, it’s the mine’s polymetallic nature, which, at these grades and widths, gives the potential for significant metal output with a low footprint. This also…

WednesdayJan 11, 2023 11:09 am

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Partnering to Support Corporate Renewables Program, Help Decarbonize Supply Chain

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, works as a platform for helping businesses in the commercial real estate industry acquire solutions for solar, cogeneration, energy storage, and electric vehicle infrastructure to improve their environmental, social and governance (“ESG”) position. “In working with global stored energy solutions leader EnerSys(R) (NYSE: ENS) on improving its carbon footprint at its Pennsylvania headquarters, Correlate Infrastructure Partners is reporting ‘officially one of the largest behind-the-meter solar installations in the United States.’ … EnerSys supports the global community with products to meet the need for efficient and affordable distribution of goods,…

TuesdayJan 10, 2023 3:01 pm

QualityStocksNewsBreaks – CubCrafters Inc. Merging High Performance, Latest Technology to Bring Unique Perspective to Access the World

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “CubCrafters President and CEO Patrick Horgan recently provided an update, announcing in a Bell2Bell podcast that the U.S. Securities and Exchange Commission (‘SEC’) has qualified the company’s Reg A+ filing, clearing the way for investors to come onboard… Horgan said that the company has booked orders already awaiting fulfillment for the next two years of CubCrafters’ production schedule, and a large part of the reason for turning to public funding is to help the company grow sufficiently that it can reduce customers’ wait times,…

MondayJan 09, 2023 1:10 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space

Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market,” a recent article reads. “From its 247 acres of growing fields, the company’s harvests move into a production pipeline…

MondayJan 09, 2023 12:18 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain barrier to target tumors directly. The inability of anthracyclines to cross the blood-brain barrier has been identified as a major obstacle in treating aggressive brain tumors such as GBM and creates an opportunity for CNS…

Site Search

Company Search

Category: Stock Spotlight